Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II

Des Jarlais, Don C.; Perlis, Theresa E.; Stimson, Gerry V.; Poznyak, Vladimir
January 2006
BMC Public Health;2006, Vol. 6 Issue 1, p54
Academic Journal
Case Study
Background: Successful cross-national research requires methods that are both standardized across sites and adaptable to local conditions. We report on the development and implementation of the methodology underlying the survey component of the WHO Drug Injection Study Phase II - a multi-site study of risk behavior and HIV seroprevalence among Injecting Drug Users (IDUs). Methods: Standardized operational guidelines were developed by the Survey Coordinating Center in collaboration with the WHO Project Officer and participating site Investigators. Throughout the duration of the study, survey implementation at the local level was monitored by the Coordinating Center. Surveys were conducted in 12 different cities. Prior rapid assessment conducted in 10 cities provided insight into local context and guided survey implementation. Where possible, subjects were recruited both from drug abuse treatment centers and via street outreach. While emphasis was on IDUs, non-injectors were also recruited in cities with substantial non-injecting use of injectable drugs. A structured interview and HIV counseling/testing were administered. Results: Over 5,000 subjects were recruited. Subjects were recruited from both drug treatment and street outreach in 10 cities. Non-injectors were recruited in nine cities. Prior rapid assessment identified suitable recruitment areas, reduced drug users' distrust of survey staff, and revealed site-specific risk behaviors. Centralized survey coordination facilitated local questionnaire modification within a core structure, standardized data collection protocols, uniform database structure, and cross-site analyses. Major site-specific problems included: questionnaire translation difficulties; locating affordable HIV-testing facilities; recruitment from drug treatment due to limited/selective treatment infrastructure; access to specific sub-groups of drug users in the community, particularly females or higher income groups; security problems for users and interviewers, hostility from local drug dealers; and interference by local service providers. Conclusion: Rapid assessment proved invaluable in paving the way for the survey. Central coordination of data collection is crucial. While fully standardized methods may be a research ideal, local circumstances may require substantial adaptation of the methods to achieve meaningful local representation. Allowance for understanding of local context may increase rather than decrease the generalizability of the data


Related Articles

  • Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1-Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview. Lv, M.; Xu, H. // Current Medicinal Chemistry;Jun2010, Vol. 17 Issue 18, p1874 

    According to World Health Organization (WHO)/Joint United Nations Programme on human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) (UNAIDS) Report in 2007, 33.2 million people are living with HIV, 2.5 million ones have been newly infected with HIV, and 2.1 million ones...

  • Making blood safe the world over. Hensley, Scott // Modern Healthcare;04/24/2000, Vol. 30 Issue 17, p28 

    Reports that the World Health Organization made a trustworthy blood supply the theme of its annual World Health Day. Objective of the blood supply theme; Condition of HIV infection worldwide; Preparation of the United States Food and Drug Administration on blood-related diseases.

  • In the news.  // Nature Reviews Microbiology;Dec2010, Vol. 8 Issue 12, p842 

    The article offers world news briefs related to disease outbreaks. The United Nations Food and Agricultural Organization announced that it will cease field surveillance of rinderpest, an infection which killed millions of cattle in Asia. According to a new study, there are about 205,000 deaths...

  • WHO Documents Worldwide Need for Better Drug Abuse Treatment--and Access to It. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;8/1/2012, Vol. 308 Issue 5, p442 

    The article provides information on the demand of the World Health Organization (WHO) on the treatment of drug use disorders. According to the WHO drug use disorders is a global problem but many countries do not take it in consideration. According to director of the department of mental health...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Dec2008, Vol. 22 Issue 12, p1021 

    The article offers news briefs related to HIV antiviral agents in the U.S. The World Health Organization (WHO) advises doctors to start early the treatment of HIV-infected babies to eliminate the bad effects of the treatment. Quest Clinical researchers reveal that etravirine does not contain...

  • FDA Curtails Antibiotic Overuse in Livestock, But US Still Trails Global Standards. Otrompke, John // Holistic Primary Care;Winter2012, Vol. 13 Issue 4, p5 

    The article reports on the FDA's order prohibiting the use of certain antibiotics like cephalosporins in livestock.

  • HIV/AIDS situation, WHO Western Pacific Region, 1998.  // Weekly Epidemiological Record;4/7/2000, Vol. 75 Issue 14, p110 

    Reports the number of HIV and AIDS cases in the World Health Organization Western Pacific Region. List of countries with declining HIV prevalence; Determination of sexually transmitted infections other than HIV; Assessment on the gonococcal susceptibility of HIV to antimicrobials.

  • New HIV cases declining. Collier, Roger // CMAJ: Canadian Medical Association Journal;1/12/2010 Supplement, Vol. 182, pE50 

    The article reports on a data released by a joint publication of the United Nations Programme on HIV/AIDS and the World Health Organization according to which new cases of Human Influenza Virus (HIV) infection have decreased by 17 percent since 2001.

  • AIDS: global lessons from a global epidemic. Mann, Jonathan; Wilson, Mary E. // BMJ: British Medical Journal (International Edition);12/18/93-12/25/93, Vol. 307 Issue 6919, p1574 

    Focuses on the prevalence of HIV epidemic. Role of the World Health Organization in the development of warning system for the emergence of diseases; Identification of microbial threats to health; Factors affecting the emergence of diseases.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics